Code | 4826D | ||||||||||
MA number | 44/0138/20-S | ||||||||||
Product Form: | cps dur 30x1x25 mg (blis.Al/OPA/Al/PVC-jednotliv.dáv.) | ||||||||||
MA Status: | R - Valid Marketing Authorisation | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Farmak International Sp. z o.o., Poland | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 19.06.2020 |
Validity: | 19.06.2025 |
SPC: | SPC_Sunitinib FMK 25 mg tvrdé kapsuly_10.2023.pdf |
PIL: | PIL_Sunitinib FMK 25 mg tvrdé kapsuly_10.2023.pdf |
Safety feature | Yes |
Data update: | 17.10.2023 |